Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …

Prostate cancer is the second most common cancer in men worldwide, with a wide spectrum
of biologic behavior ranging from indolent low-risk disease to highly aggressive castration …

The aim of this guideline is to provide minimum standards for the performance and
interpretation of 18 F-NaF PET/CT scans. Standard acquisition and interpretation of nuclear …

Simple Summary The prognosis for metastatic prostate cancer patients remains poor.
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer and is a …

Objectives To determine the diagnostic accuracy of 68 gallium prostate-specific membrane
antigen (PSMA)-based positron emission tomography/computed tomography (PET/CT) in …

The use of 18 F-sodium fluoride (18 F-NaF) with PET/CT is increasing. This resurgence of an
old tracer has been fueled by several factors including superior diagnostic performance over …

Diagnosis and treatment of bone metastasis requires various types of measures, specialists
and caregivers. To provide better diagnosis and treatment, a multidisciplinary team …

Purpose This meta-analysis aims to establish the diagnostic performance of 18 F-NaF-
PET/CT for the detection of bone metastases in prostate cancer patients. The performance of …

The management of advanced prostate cancer has changed substantially with the
availability of multiple effective novel treatments, which has led to improved disease survival …

We prospectively evaluated and compared the diagnostic performance of 99mTc-
hydroxyethylene-diphosphonate (99mTc-HDP) planar bone scintigraphy (pBS), 99mTc-HDP …